Article 23 Mar 2015 FDA Issues Revised Draft Guidance On Disclosures Of Risk Information In Consumer-Friendly Print Advertisements And Promotional Labeling United States Healthcare
Article 13 Nov 2014 CMS Finalizes Proposal To Remove Continuing Medical Education Exclusion From Sunshine Act Regulations United States Healthcare
Article 08 Aug 2014 CMS Proposes Removing CME Exclusion From Sunshine Act Regulations, Citing Redundancy With Indirect Payment Exclusion United States Healthcare
Article 03 Jun 2014 Identifying And Mitigating Liabilities In Medical Device M&A United States Commercial
Article 10 Mar 2014 FDA Updates Guidance Addressing Distribution Of Scientific And Medical Publications On Unapproved New Uses United States Healthcare
Article 15 Feb 2014 China Compliance Update: Commercial Bribery Risks Remain Very Real In China China Healthcare
Article 29 Jan 2014 FDA Issues Draft Guidance Addressing Postmarket Submission Requirements For Internet-based Promotional Materials United States Healthcare
Article 25 Jan 2014 New Law Extends Federal Oversight Of Compounding Pharmacies, Establishes National Drug Track-and-Trace Requirements United States Healthcare
Article 09 May 2013 Draft Guidance Outlines Recommendations For Formal Meetings Between FDA And Biosimilar Sponsors And Applicants United States Healthcare